Gene editing therapeutics based on mRNA delivery
- PMID: 37516409
- DOI: 10.1016/j.addr.2023.115026
Gene editing therapeutics based on mRNA delivery
Abstract
The field of gene editing has received much attention in recent years due to its immense therapeutic potential. In particular, gene editing therapeutics, such as the CRISPR-Cas systems, base editors, and other emerging gene editors, offer the opportunity to address previously untreatable disorders. This review aims to summarize the therapeutic applications of gene editing based on mRNA delivery. We introduce gene editing therapeutics using mRNA and focus on engineering and improvement of gene editing technology. We subsequently examine ex vivo and in vivo gene editing techniques and conclude with an exploration of the next generation of CRISPR and base editing systems.
Keywords: Base editing; CRISPR; Delivery; Gene editing; Gene therapy; Nanoparticle; mRNA.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
